Filing Details

Accession Number:
0001232524-10-000032
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-03 12:00:00
Reporting Period:
2010-12-03
Filing Date:
2010-12-03
Accepted Time:
2010-12-03 19:14:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Inc JAZZ Pharmaceutical Preparations (2834) 050563787
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397267 A Carol Gamble C/O Jazz Pharmaceuticals, Inc.
3180 Porter Drive
Palo Alto CA 94304
Svp, Gc And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-03 8,885 $1.25 16,089 No 4 M Direct
Common Stock Acquisiton 2010-12-03 16,115 $7.96 32,204 No 4 M Direct
Common Stock Disposition 2010-12-03 25,000 $17.77 7,204 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2010-12-03 8,885 $0.00 8,885 $1.25
Common Stock Option (right to buy) Disposition 2010-12-03 16,115 $0.00 16,115 $7.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,115 2019-01-20 No 4 M Direct
28,885 2018-05-15 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.70 to $17.90, inclusive.
  2. The reporting person undertakes to provide to Jazz Pharmaceuticals, Inc., any security holder of Jazz Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in footnote (1) to this Form 4.
  3. The options vest over three years measured from the vesting commencement date, January 21, 2009, with 1/3rd vesting on the first anniversary of the vesting commencment date and the remainder vesting in 24 equal monthly installments thereafter.
  4. The options vest over four years measured from the vesting commencement date, May 16, 2008, with 1/4th vesting on the first anniversary of the vesting commencment date and the remainder vesting in 36 equal monthly installments thereafter.